Trial intelligence / Profile preview

Applying Wolbachia to Eliminate Dengue (AWED)

NCT03055585Terminated

Sponsor
Universitas Gadjah Mada
Start
Nov 2017
Primary completion
Mar 2020
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Universitas Gadjah Mada. Primary endpoint: Relative risk of dengue in Wolbachia-treated versus untreated clusters at 36 months. Started Nov 2017; status: terminated.

Beyond the preview

Go deeper on NCT03055585.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03055585.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call